Anticipating Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Testing, Licensure, and Recommendations for Use - 19/08/20
Doi : 10.1016/j.jpeds.2020.06.048
Kathryn M. Edwards, MD 1, ⁎ 
, Walter A. Orenstein, MD 2
, Walter A. Orenstein, MD 2 1 Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN
2 Departments of Medicine and Pediatrics, Emory University School of Medicine, Atlanta, GA
∗Reprint requests: Kathryn M. Edwards, MD, Division of Infectious Diseases, Vanderbilt University Medical Center, 2201 West End Ave, Nashville, TN 37232Division of Infectious DiseasesVanderbilt University Medical Center2201 West End AveNashvilleTN37232
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Abbreviations : ACIP, CDC, COVID-19, DSMC, FDA, NVICP, SARS-CoV-2, VRBPAC
Le texte complet de cet article est disponible en PDF.
Plan
| K.E. receives contract funding from the National Institutes of Health and Centers for Disease Control and Prevention and is a consultant to BioNet, IBM, and Merck and is on Data Safety and Monitoring Committees for Sanofi, Moderna, Pfizer, and X-4 Pharma. W.O. declares no conflicts of interest. |
© 2020
Elsevier Inc. Tous droits réservés.
Vol 224
P. 124-128 - septembre 2020 Retour au numéro
Article précédent
- Fetal Growth Restriction and Hypertension in the Offspring: Mechanistic Links and Therapeutic Directions
- Arvind Sehgal, Barbara T. Alexander, Janna L. Morrison, Andrew M. South
- Multisystem Inflammatory Syndrome in Children and Kawasaki Disease: Two Different Illnesses with Overlapping Clinical Features
- Anne H. Rowley
Bienvenue sur EM-consulte, la référence des professionnels de santé.